|Amlodipine||Calcium channel blocker|
|Celecoxib||Nonsteroidal anti-inflammatory drug (NSAID)|
Amlodipine/celecoxib, sold under the brand name Consensi, is a fixed-dose combination medication used to treat both hypertension and osteoarthritis at the same time in adults. It contains amlodipine besylate and celecoxib. It is taken by mouth.
The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash.
It was approved for medical use in the United States in May 2018.
Amlodipine/celecoxib was approved for use in the United States in May 2018.
- "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.
- Smith SM, Cooper-DeHoff RM (February 2019). "Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis". The American Journal of Medicine. 132 (2): 172–174. doi:10.1016/j.amjmed.2018.08.027. PMID 30240679. S2CID 52312672.
- "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.
- "Amlodipine mixture with celecoxib". Drug Information Portal. U.S. National Library of Medicine.